CIK 0001631574 · Large accelerated filer
Wave Life Sciences, Inc.
Sign in to watch- Ticker
- WVE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-949-2900
- Business address
- 733 CONCORD AVENUE, CAMBRIDGE, MA, 02138
- Former names
- Wave Life Sciences Ltd., Wave Life Sciences LTD., WAVE Life Sciences Ltd., Wave Life Sciences Pte Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-08 | Francis Chris See Remarks | Sale 10b5-1 | −9,375 | $15.00 | $141K | 25,000 |
| 2025-12-08 | Francis Chris See Remarks | Option exercise 10b5-1 | +37,500 | $3.14 | $118K | 62,500 |
| 2025-12-08 | Francis Chris See Remarks | Sale 10b5-1 | −37,500 | $14.08 | $528K | 25,000 |
| 2025-12-08 | Francis Chris See Remarks | Option exercise 10b5-1 | +17,900 | $3.87 | $69K | 42,900 |
| 2025-12-08 | Francis Chris See Remarks | Sale 10b5-1 | −17,900 | $15.00 | $269K | 25,000 |
| 2025-12-08 | Francis Chris See Remarks | Option exercise 10b5-1 | +122,349 | $4.75 | $581K | 147,349 |
| 2025-12-08 | Francis Chris See Remarks | Sale 10b5-1 | −122,349 | $14.20 | $1.7M | 25,000 |
| 2025-12-08 | Francis Chris See Remarks | Option exercise 10b5-1 | +50,000 | $10.48 | $524K | 75,000 |
| 2025-12-08 | Francis Chris See Remarks | Sale 10b5-1 | −50,000 | $16.00 | $800K | 25,000 |
| 2025-12-08 | Francis Chris See Remarks | Option exercise 10b5-1 | +22,500 | $2.83 | $64K | 47,500 |
| 2025-12-08 | Francis Chris See Remarks | Sale 10b5-1 | −22,500 | $14.08 | $317K | 25,000 |
| 2025-12-08 | Francis Chris See Remarks | Option exercise · Share Option (right to buy) 10b5-1 | −75,000 | 9,375 | ||
| 2025-12-08 | Francis Chris See Remarks | Option exercise · Share Option (right to buy) 10b5-1 | −125,300 | 161,100 | ||
| 2025-12-08 | Francis Chris See Remarks | Option exercise · Share Option (right to buy) 10b5-1 | −168,231 | 76,469 | ||
| 2025-12-08 | Francis Chris See Remarks | Option exercise · Share Option (right to buy) 10b5-1 | −50,000 | 0 | ||
| 2025-12-08 | Francis Chris See Remarks | Option exercise · Share Option (right to buy) 10b5-1 | −22,500 | 0 | ||
| 2025-12-08 | Moran Kyle Chief Financial Officer | Option exercise 10b5-1 | +60,000 | $2.83 | $170K | 149,218 |
| 2025-12-08 | Moran Kyle Chief Financial Officer | Sale 10b5-1 | −60,000 | $13.20 | $792K | 89,218 |
| 2025-12-08 | Moran Kyle Chief Financial Officer | Option exercise 10b5-1 | +100,000 | $3.14 | $314K | 189,218 |
| 2025-12-08 | Moran Kyle Chief Financial Officer | Sale 10b5-1 | −50,000 | $15.00 | $750K | 139,218 |
Page 6 of 13 · 255 trades